Future Impact of GPRC5D-Targeted Therapies on RRMM Treatment

Opinion
Video

Panelists discuss how the evolution of GPRC5D-targeted therapies is expected to shape future treatment approaches for relapsed/refractory multiple myeloma in community practices by offering more personalized options and improving patient outcomes.

Recent Videos
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
4 experts in this video
4 experts in this video
Related Content